CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

D-MAVsNeutral
AI Analysis

Summary

Decoy Therapeutics stockholders elected Patricia Gauthier to the company's board of directors. The company is developing Designable Multi-Antivirals (D-MAVs) targeting shared viral mechanisms.

Importance:2/10
Sentiment:
0.00
board_electioncorporate_governanceantivirals
Related Companies

Read the original article

Published by PR Newswire Biotech on July 15, 2026 1:24 PM

Read Original